These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8852543)

  • 41. Safety of the calcium antagonist lacidipine evaluated from a phase III-IV trial database.
    Lindholm LH; Tcherdakoff P; Zanchetti A
    J Hypertens Suppl; 1996 Sep; 14(2):S15-20. PubMed ID: 8934373
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hemodynamic effects of nisoldipine in chronic congestive heart failure.
    Vogt A; Kreuzer H
    Arzneimittelforschung; 1983; 33(6):877-9. PubMed ID: 6684444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lacidipine: a review of its use in the management of hypertension.
    McCormack PL; Wagstaff AJ
    Drugs; 2003; 63(21):2327-56. PubMed ID: 14524737
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety aspects of treatment with lacidipine--a slow-onset, long-acting calcium antagonist.
    Lindholm LH; Tcherdakoff P; Zanchetti A
    Blood Press; 1996 Jul; 5(4):241-9. PubMed ID: 8809376
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DITPA (3,5-Diiodothyropropionic Acid), a thyroid hormone analog to treat heart failure: phase II trial veterans affairs cooperative study.
    Goldman S; McCarren M; Morkin E; Ladenson PW; Edson R; Warren S; Ohm J; Thai H; Churby L; Barnhill J; O'Brien T; Anand I; Warner A; Hattler B; Dunlap M; Erikson J; Shih MC; Lavori P
    Circulation; 2009 Jun; 119(24):3093-100. PubMed ID: 19506112
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and neurohormonal effects of nicardipine hydrochloride in patients with severe chronic heart failure receiving angiotensin-converting enzyme inhibitor therapy.
    Benatar D; Hall V; Reddy S; Gheorghiade M
    Am J Ther; 1998 Jan; 5(1):25-32. PubMed ID: 10099034
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of felodipine in chronic congestive heart failure: a placebo controlled haemodynamic study at rest and during exercise and orthostatic stress.
    Kassis E; Amtorp O; Waldorff S; Fritz-Hansen P
    Br Heart J; 1987 Nov; 58(5):505-11. PubMed ID: 3314956
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lacidipine: experimental evidence of vasculoprotective properties.
    Cristofori P; Micheli D; Terron A; Gaviraghi G
    J Cardiovasc Pharmacol; 1994; 23 Suppl 5():S90-3. PubMed ID: 7609515
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of nitroglycerine on haemodynamics and on catecholamine metabolism in patients with congestive left heart failure (author's transl)].
    Klein W; Brandt D; Fluch N; Maurer E
    Acta Med Austriaca; 1980; 7(3):65-70. PubMed ID: 6784434
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Muzolimine therapy in patients with congestive heart failure in comparison with furosemide pretreatment. Effect on digoxin plasma concentration.
    Kahles H; Ertl G; Riegger G; Liebau G; Kochsiek K
    Z Kardiol; 1985; 74 Suppl 2():24-6. PubMed ID: 4002799
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of diuretics on cardiopulmonary performance in severe chronic airflow obstruction. A controlled clinical trial.
    Mathur PN; Pugsley SO; Powles AC; McEwan MP; Campbell EJ
    Arch Intern Med; 1984 Nov; 144(11):2154-7. PubMed ID: 6388521
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blood pressure and cationic transport systems during combined calcium channel blocker and calcium administration in males.
    Lijnen P; Petrov V
    Methods Find Exp Clin Pharmacol; 1996 May; 18(4):287-94. PubMed ID: 8803961
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiovascular and neurohumoral postural responses and baroreceptor abnormalities during a course of adjunctive vasodilator therapy with felodipine for congestive heart failure.
    Kassis E; Amtorp O
    Circulation; 1987 Jun; 75(6):1204-13. PubMed ID: 2882868
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term antihypertensive treatment with lacidipine, a new long-acting calcium antagonist.
    Nami R; Rizzini P; Buracchi P; Pavese G; Gennari C
    J Cardiovasc Pharmacol; 1991; 18 Suppl 11():S22-5. PubMed ID: 1725446
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The antiatherosclerotic effects of calcium antagonists.
    Paoletti R; Bernini F; Corsini A; Soma MR
    J Cardiovasc Pharmacol; 1995; 25 Suppl 3():S6-10. PubMed ID: 8852538
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lacidipine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertension.
    Lee CR; Bryson HM
    Drugs; 1994 Aug; 48(2):274-96. PubMed ID: 7527328
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of calcium antagonists on the cardiovascular system: experience with lacidipine.
    Kuschnir E
    Drugs; 1999; 57 Suppl 1():11-7. PubMed ID: 10529078
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Digitalis for the treatment in patients with heart failure].
    Sato T; Takeshi M; Ochiai M
    Nihon Rinsho; 1993 May; 51(5):1260-7. PubMed ID: 8331794
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical pharmacology of lacidipine.
    Hall ST; Harding SM; Evans GL; Pellegatti M; Rizzini P
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S9-13. PubMed ID: 1726014
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect on atrioventricular conduction of a new calcium antagonist: lacidipine. Evaluation by the Holter method].
    Frank R; Rougier I; Tonet JL; Harding S; Bons J; Fontaine G; Grosgogeat Y
    Ann Cardiol Angeiol (Paris); 1990 Jun; 39(6):363-9. PubMed ID: 2400198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.